322 related articles for article (PubMed ID: 34231067)
1. Pre- and post-procedure risk prediction models for post-endoscopic retrograde cholangiopancreatography pancreatitis.
Park CH; Park SW; Yang MJ; Moon SH; Park DH
Surg Endosc; 2022 Mar; 36(3):2052-2061. PubMed ID: 34231067
[TBL] [Abstract][Full Text] [Related]
2. A Risk Prediction Model for Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis After Stent Insertion for Malignant Biliary Obstruction: Development and Validation.
Fu Z; Song J; Pi Y; Sun X; Liu M; Xiao Z; Chen J
Dig Dis Sci; 2023 Apr; 68(4):1574-1584. PubMed ID: 35989385
[TBL] [Abstract][Full Text] [Related]
3. Risk factors of pancreatitis after endoscopic retrograde cholangiopancreatography in patients with biliary tract diseases.
Chi JY; Ma LY; Zou JC; Ma YF
BMC Surg; 2023 Mar; 23(1):62. PubMed ID: 36959589
[TBL] [Abstract][Full Text] [Related]
4. Development and external validation of a nomogram for prediction of post-endoscopic retrograde cholangiopancreatography pancreatitis.
Fukuda R; Hakuta R; Nakai Y; Hamada T; Takaoka S; Tokito Y; Suzuki Y; Oyama H; Kanai S; Noguchi K; Suzuki T; Ishigaki K; Saito K; Saito T; Takahara N; Mizuno S; Ito Y; Kogure H; Fujishiro M
Pancreatology; 2023 Nov; 23(7):789-796. PubMed ID: 37666733
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Using 4-Hour Post-Endoscopic Retrograde Cholangiopancreatography Serum Amylase and Lipase Levels.
Lee YK; Yang MJ; Kim SS; Noh CK; Cho HJ; Lim SG; Hwang JC; Yoo BM; Kim JH
J Korean Med Sci; 2017 Nov; 32(11):1814-1819. PubMed ID: 28960034
[TBL] [Abstract][Full Text] [Related]
6. Impact of pancreatic fat on the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis.
Park CH; Chung MJ; Park DH; Min S; Park SW
Surg Endosc; 2022 Aug; 36(8):5734-5742. PubMed ID: 35099627
[TBL] [Abstract][Full Text] [Related]
7. Multicenter prospective cohort study of adverse events associated with biliary endoscopic retrograde cholangiopancreatography: Incidence of adverse events and preventive measures for post-endoscopic retrograde cholangiopancreatography pancreatitis.
Fujita K; Yazumi S; Matsumoto H; Asada M; Nebiki H; Matsumoto K; Maruo T; Takenaka M; Tomoda T; Onoyama T; Kurita A; Ueki T; Katayama T; Kawamura T; Kawamoto H;
Dig Endosc; 2022 Sep; 34(6):1198-1204. PubMed ID: 34963021
[TBL] [Abstract][Full Text] [Related]
8. Temporal trend and factors associated with post-endoscopic retrograde cholangiopancreatography pancreatitis in children in the USA: a nationwide, retrospective cohort study.
Zhu R; Wu S; Xu J; Wang R; Cheng Y; Xu Y; Chen C; Wu C
Eur J Pediatr; 2023 May; 182(5):2273-2282. PubMed ID: 36872379
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail.
Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Hikichi T; Ohira H
World J Gastroenterol; 2018 Jun; 24(22):2392-2399. PubMed ID: 29904246
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors and Risk Assessment for Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
Zhao C; Dai T; Qian J; Ge Z
J Coll Physicians Surg Pak; 2024 Apr; 34(4):413-418. PubMed ID: 38576282
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic retrograde cholangiopancreatography-related adverse events in Korea: A nationwide assessment.
Jang DK; Kim J; Paik CN; Kim JW; Lee TH; Jang JY; Yoon SB; Lee JK
United European Gastroenterol J; 2022 Feb; 10(1):73-79. PubMed ID: 34953054
[TBL] [Abstract][Full Text] [Related]
12. Frequency of Post Endoscopic Retrograde Cholangiopancreatography Acute Pancreatitis in an Academic Hospital of Bangladesh.
Islam MS; Khalil MM; Hossain MI; Datta RK; Podder S; Khan ST; Ahmed F; Ahmed F; Rahman MM; Kibria MG
Mymensingh Med J; 2024 Jan; 33(1):133-139. PubMed ID: 38163784
[TBL] [Abstract][Full Text] [Related]
13. Does endoscopic sphincterotomy contribute to the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis after endoscopic biliary stenting for malignant biliary obstruction? A multicenter prospective cohort study.
Nebiki H; Fujita K; Yazumi S; Takenaka M; Maruo T; Matsumoto K; Asada M; Eguchi T; Matsubara T; Yasumura S; Matsumoto H; Tamura T; Marui S; Hasegawa K; Mitoro A; Masuda A; Takada R; Minami R; Ogura T; Hoki N; Funatsu E; Kurita A; Onoyama T; Tomoda T; Ueki T; Yamasaki T; Sakata Y; Katayama T; Kawamura T; Kawamoto H
Surg Endosc; 2023 May; 37(5):3463-3470. PubMed ID: 36575219
[TBL] [Abstract][Full Text] [Related]
14. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
[TBL] [Abstract][Full Text] [Related]
15. Positive correlation between pancreatic volume and post-endoscopic retrograde cholangiopancreatography pancreatitis.
Maruyama H; Shiba M; Ishikawa-Kakiya Y; Kato K; Ominami M; Fukunaga S; Otani K; Hosomi S; Tanaka F; Kamata N; Taira K; Nagami Y; Yamagami H; Tanigawa T; Watanabe T; Yamamoto A; Kabata D; Shintani A; Fujiwara Y
J Gastroenterol Hepatol; 2020 May; 35(5):769-776. PubMed ID: 31618801
[TBL] [Abstract][Full Text] [Related]
16. Rectal Indomethacin Reduces Pancreatitis in High- and Low-Risk Patients Undergoing Endoscopic Retrograde Cholangiopancreatography.
Thiruvengadam NR; Forde KA; Ma GK; Ahmad N; Chandrasekhara V; Ginsberg GG; Ho IK; Jaffe D; Panganamamula KV; Kochman ML
Gastroenterology; 2016 Aug; 151(2):288-297.e4. PubMed ID: 27215656
[TBL] [Abstract][Full Text] [Related]
17. Cooling the papilla with ice water in preventing post-ERCP pancreatitis (ice water challenge study).
Azuma S; Kurita A; Katayama T; Iwano K; Iimori K; Kawai Y; Sawada K; Yazumi S
Surg Endosc; 2022 Aug; 36(8):6002-6006. PubMed ID: 34977992
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for post-endoscopic retrograde cholangiopancreatography (ERCP) abdominal pain in patients without post-ERCP pancreatitis.
Chen MJ; Zheng RH; Cao J; Yao YL; Wang L; Zou XP
Hepatobiliary Pancreat Dis Int; 2022 Jun; 21(3):285-292. PubMed ID: 34924299
[TBL] [Abstract][Full Text] [Related]
19. Nafamostat Mesylate is Not Effective in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
Matsumoto T; Okuwaki K; Imaizumi H; Kida M; Iwai T; Yamauchi H; Kaneko T; Hasegawa R; Masutani H; Tadehara M; Adachi K; Watanabe M; Kurosu T; Tamaki A; Kikuchi H; Ohno T; Koizumi W
Dig Dis Sci; 2021 Dec; 66(12):4475-4484. PubMed ID: 33495919
[TBL] [Abstract][Full Text] [Related]
20. Reduced risk of post ERCP pancreatitis in statin users.
Hadi YB; Naqvi SF; Abdelqader A; Kupec J; Nasr J
BMC Gastroenterol; 2020 Apr; 20(1):125. PubMed ID: 32326889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
